triamcinolone has been researched along with Cancer of Prostate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, A; Marhamati, S; Shaw, NM; Sussman, R; Venkatesan, K | 1 |
| Eltahawy, E; Gur, U; Jordan, GH; Schlossberg, SM; Virasoro, R | 1 |
| ALBANESE, AA; LORENZE, EJ; ORTO, LA; SMULLYAN, I | 1 |
| Colocci, N; Feldman, D; Krishnan, AV; Srinivas, S | 1 |
| Cole, D; Durham, JP; Mawhinney, MG; Sosnowski, J; Stetter-Neel, C | 1 |
| Brive, L; Ely, KR; Feldman, D; Krishnan, AV; Peehl, DM; Swami, S; Zhao, XY | 1 |
1 trial(s) available for triamcinolone and Cancer of Prostate
| Article | Year |
|---|---|
Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Disease Progression; Glucocorticoids; Humans; Hydrocortisone; Male; Middle Aged; Point Mutation; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Triamcinolone | 2006 |
5 other study(ies) available for triamcinolone and Cancer of Prostate
| Article | Year |
|---|---|
Recurrent vesicourethral anastomotic stenosis following treatment for prostate cancer: an effective endoscopic treatment using bipolar plasma button and triamcinolone.
Topics: Anastomosis, Surgical; Constriction, Pathologic; Contracture; Humans; Male; Neoplasm Recurrence, Local; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Triamcinolone; Urinary Bladder Neck Obstruction | 2022 |
Management of recurrent anastomotic stenosis following radical prostatectomy using holmium laser and steroid injection.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Constriction, Pathologic; Humans; Injections; Lasers, Solid-State; Male; Middle Aged; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Secondary Prevention; Treatment Outcome; Triamcinolone; Urinary Bladder; Urinary Incontinence; Urinary Sphincter, Artificial | 2008 |
NUTRITIONAL AND METABOLIC EFFECTS OF SOME NEWER STEROIDS. III. STANOZOLOL.
Topics: Amputation, Surgical; Anabolic Agents; Blood Chemical Analysis; Dexamethasone; Diabetic Neuropathies; Geriatrics; Hematocrit; Hemiplegia; Hemoglobinometry; Hip; Humans; Liver; Male; Multiple Sclerosis; Neoplasm Metastasis; Nitrogen; Prednisone; Prostatic Neoplasms; Proteins; Stanozolol; Steroids; Testosterone Congeners; Triamcinolone; Urine; Water-Electrolyte Balance | 1964 |
Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
Topics: Animals; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Glucocorticoids; Male; Prostatic Neoplasms; Protein Kinase C; Rats; Sphingosine; Time Factors; Triamcinolone; Tumor Cells, Cultured | 1997 |
A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.
Topics: Androgen Antagonists; Androgens; Anilides; Binding, Competitive; Cell Line; Dihydrotestosterone; Fludrocortisone; Genes, Reporter; Glucocorticoids; Humans; Hydrocortisone; Kinetics; Ligands; Male; Mifepristone; Models, Molecular; Mutation; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Radioligand Assay; Receptors, Androgen; Tosyl Compounds; Triamcinolone | 2002 |